Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ephraim ResourcesASX:EPA Cash-to-Debt is 0.01 as of Dec. 2017, which is 100% below its 10-year median of 77.28. The stock has 1 warning sign investors should review.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Ephraim Resources's cash to debt ratio for the quarter that ended in Dec. 2017 was 0.01.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Ephraim Resourcescouldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2017.
The historical rank and industry rank for Ephraim Resources's Cash-to-Debt or its related term are showing as below:
ASX:EPA'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 77.28 Max: No Debt
Current: No Debt
During the past 13 years, Ephraim Resources's highest Cash to Debt Ratio was No Debt. The lowest was 0.00. And the median was 77.28.
ASX:EPA's Cash-to-Debt is not ranked
in the Biotechnology industry.
Industry Median: 6.43
vs ASX:EPA: No Debt
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Ephraim Resources Cash-to-Debt Related Terms
Ephraim Resources Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Ephraim Resources's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Biotechnology subindustry, Ephraim Resources's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ephraim Resources Cash-to-Debt vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ephraim Resources's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Ephraim Resources's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ephraim Resources (ASX:EPA) has a Cash-to-Debt of 0.01 as of Dec. 2017. This is 100% below median its historical median of 77.28.
Is Ephraim Resources' Cash-to-Debt too high?
Ephraim Resources' current Cash-to-Debt of 0.01 is 100% below median its 10-year median of 77.28. The Biotechnology industry median Cash-to-Debt is 6.43. Ephraim Resources' value of 0.01 is 99.8% below this industry median.
How does Ephraim Resources' Cash-to-Debt compare to competitors?
Ephraim Resources' Cash-to-Debt of 0.01 can be compared against companies in the Biotechnology industry. The industry median Cash-to-Debt is 6.43. Ephraim Resources' value of 0.01 is 99.8% below this benchmark. While the company's 10-year median is 77.28 vs. the industry median of 6.43, Ephraim Resources has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Biotechnology company?
The median Cash-to-Debt among Biotechnology companies is 6.43, based on 1,401 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ephraim Resources's current Cash-to-Debt of 0.01 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Cash-to-Debt is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ephraim Resources's current Cash-to-Debt is 0.01, which is 100% below median its own 10-year median of 77.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ephraim Resources stock overvalued right now?
Ephraim Resources (ASX:EPA) has a current Cash-to-Debt of 0.01. The current Cash-to-Debt is 0.01, which is 100% below median its 10-year median of 77.28 and 99.8% below the Biotechnology industry median of 6.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Ephraim Resources (ASX:EPA), the current Cash-to-Debt is 0.01 as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ephraim Resources Ltd is an Australia-based company involved in agricultural biogenetics research and experimentation, licensing and consultancy, with a focus on nipah palm breeding, tissue culture, cultivation and plantation, and producing sugar syrup from nipah palm sap.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EPA has been successfully added to your 
